12 completed. 12 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 12 |
| Phase 1 | 2 | Completed 2 |
Follow Vestibular Diseases: new trials by email Literature Review of Vestibular Diseases trials Research Report on Vestibular Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Automated Robotic Maneuvering System (RMS) vs Manual Reposition Maneuver in Treatment of Benign Paroxysmal Positional Vertigo (BPPV) Automated vertigo repositioning chair, Canalith Reposition Maneuver - Benign Paroxysmal Positional Vertigo | Phase 1 / Phase 2 | Completed | Stratejik Yenilikci Girisimler Ltd. | 75 | 2022-02-15 | 2022-04-29 |
| AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery Intranasal Drug, Oral Tablet, Intranasal Placebo - Vestibular Vertigo | Phase 2 | Completed | Auris Medical AG | 124 | 2019-07-18 | 2023-09-14 |
| Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT) VRT Care - Vertigo, Dizziness | Phase 2 | Completed | Johns Hopkins University | 130 | 2017-12-04 | 2025-12-26 |
| SPI-1005 for the Treatment of Patients With Meniere's Disease 200mg SPI-1005 BID, 400mg SPI-1005 BID, Placebo - Meniere's Disease | Phase 2 | Completed | Sound Pharmaceuticals, Incorporated | 149 | 2017-09-28 | 2023-09-18 |
| SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity Placebo, SPI-1005 Ebselen 200mg Capsule x1, SPI-1005 Ebselen 200mg Capsule x2 - Ototoxicity | Phase 2 | Completed | Sound Pharmaceuticals, Incorporated | 35 | 2017-07-21 | 2026-07-16 |
| Study to Evaluate SPI-1005 in Adults With Meniere's Disease SPI-1005 - Meniere's Disease | Phase 1 / Phase 2 | Completed | Sound Pharmaceuticals, Incorporated | 40 | 2015-12-01 | 2026-06-29 |
| Study of Lamotrigine to Treat Ménière's Disease Lamotrigine, Placebo - Meniere's Disease, Ménière's Vertigo | Phase 2 | Completed | Dent Neuroscience Research Center | 15 | 2014-06-01 | 2022-06-22 |
| A Clinical Trial To Evaluate Efficacy And Safety Of Levophencynonate Hydrochloride In Patient With Vertigo Levophencynonate Hydrochloric, Placebo - Vertigo | Phase 2 | Completed | Sihuan Pharmaceutical Holdings Group Ltd. | 98 | 2014-01-01 | 2016-04-15 |
| OTO-104 for the Treatment of Meniere's Disease OTO-104, Placebo - Meniere's Disease | Phase 2 | Completed | Otonomy, Inc. | 154 | 2013-11-01 | 2015-09-03 |
| Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo Gufoni, Vibration, Sham - Benign Paroxysmal Positional Vertigo | Phase 2 | Completed | Keimyung University Dongsan Medical Center | 209 | 2013-09-01 | 2016-03-11 |
| Prednisone Treatment for Vestibular Neuronitis Prednisone - Vestibular Diseases, Vestibular Neuronitis | Phase 2 | Completed | Carmel Medical Center | 17 | 2005-09-01 | 2007-11-06 |
| Treatments for Benign Paroxysmal Positional Vertigo (BPPV) Canalith repositioning maneuver (Epley maneuver), Semont maneuver, Brandt-Daroff exercises - Vertigo | Phase 2 | Completed | Baylor College of Medicine | 150 | 1998-10-01 | 2012-07-26 |
Vertigo (10) · Hearing Loss (4) · Meniere Disease (4) · Tinnitus (4) · Benign Paroxysmal Positional Vertigo (3) · Dizziness (3) · Vestibular Neuronitis (2) · Cystic Fibrosis (1) · Emergencies (1) · Ototoxicity (1) · Speech (1) · Stroke (1)
Ear Diseases (12) · Labyrinth Diseases (12) · Nervous System Diseases (12) · Otorhinolaryngologic Diseases (12) · Neurologic Manifestations (11) · Pathological Conditions, Signs and Symptoms (11) · Signs and Symptoms (11) · Sensation Disorders (7) · Endolymphatic Hydrops (4) · Hearing Disorders (4) · Cranial Nerve Diseases (2) · Pathologic Processes (2) · Retrocochlear Diseases (2) · Vestibulocochlear Nerve Diseases (2)
ebselen (3) · Administration, Intranasal (1) · Lamotrigine (1) · Prednisone (1) · Tablets (1) · Vibration (1) · microcrystalline cellulose (1) · salicylhydroxamic acid (1)
Sound Pharmaceuticals, Incorporated (3) · Auris Medical AG (1) · Baylor College of Medicine (1) · Carmel Medical Center (1) · Dent Neuroscience Research Center (1) · Johns Hopkins University (1) · Keimyung University Dongsan Medical Center (1) · Otonomy, Inc. (1) · Sihuan Pharmaceutical Holdings Group Ltd. (1) · Stratejik Yenilikci Girisimler Ltd. (1)
United States (7) · China (1) · France (1) · Israel (1) · South Korea (1) · Turkey (Türkiye) (1)
Jonathan Kil, MD (3) · Avi Shupak, MD (1) · Avishai Golz, MD (1) · Carl LeBel, PhD (1) · David Newman-Toker, MD, PhD (1) · Elhanan Greenberg, ND (1) · Helen Cohen, EdD (1) · Hyun Ah Kim (1) · Hyung Lee (1) · Itzhak Braverman, MD (1) · Lixin Zhang, MD, PhD (1) · Murat H Ozkul, M.D. (1) · Yansheng Li, PHD (1)
PMID 15011204, PMID 15103195, PMID 16151355, PMID 28220291, PMID 32483557, PMID 33675203, PMID 34510123, PMID 37166022
2018 (1), R01DC003602 (1), U01DC013778 (1)